Building on the Evidence—Role of Echocardiographic Parameters for Understanding Outcomes in Cardiac Amyloidosis
- 5 October 2025
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 38 (12) , 1159-1160
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Echocardiographic Phenotypic Differences Between Light-Chain and Transthyretin Cardiac Amyloid and Relation to OutcomeJournal of the American Society of Echocardiography, 2025
- 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac AmyloidosisJACC, 2023
- Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosisEuropean Heart Journal, 2020
- Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic RolesJACC: Cardiovascular Imaging, 2019
- Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain AmyloidosisCirculation: Cardiovascular Imaging, 2018
- Left Ventricular Structure and Function in Transthyretin-Related Versus Light-Chain Cardiac AmyloidosisCirculation, 2014
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain MeasurementsJournal of Clinical Oncology, 2012
- Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse HeartsCirculation, 2001